BIOADAPTIVES, INC. financial data

Symbol
BDPT on OTC
Location
Las Vegas, NV
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12% % 361%
Quick Ratio 2.2% % 315%
Debt-to-equity -112% % -7.6%
Return On Equity 77% % 73%
Return On Assets -575% % 61%
Operating Margin -14411% % -777%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12,008,659 shares -99%
Common Stock, Shares, Outstanding 10,938,725 shares -99%
Entity Public Float $246,461 USD
Common Stock, Value, Issued $1,093 USD -99%
Weighted Average Number of Shares Outstanding, Basic 895,760,225 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 10,239,290 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $7,851 USD -60%
Cost of Revenue $2,937 USD -78%
General and Administrative Expense $850,867 USD 622%
Operating Income (Loss) $1,131,395 USD -246%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $379,502 USD -908%
Net Income (Loss) Attributable to Parent $1,106,340 USD -39%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted -0.04 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $261,885 USD 196%
Marketable Securities, Current $0 USD
Inventory, Net $44,228 USD
Assets, Current $108,860 USD 135%
Property, Plant and Equipment, Net $15,500 USD
Intangible Assets, Net (Excluding Goodwill) $18,000 USD
Assets $124,360 USD 168%
Accrued Liabilities, Current $180,837 USD 24%
Liabilities, Current $1,589,570 USD -14%
Liabilities $1,589,570 USD -14%
Retained Earnings (Accumulated Deficit) $9,897,858 USD -13%
Stockholders' Equity Attributable to Parent $1,465,210 USD 19%
Liabilities and Equity $124,360 USD 168%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $97,906 USD -138%
Common Stock, Shares Authorized 1,250,000,000 shares 0%
Common Stock, Shares, Issued 10,938,725 shares -99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59,273 USD 35%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $718,837 USD 23%
Property, Plant and Equipment, Gross $18,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $718,837 USD 23%
Preferred Stock, Shares Authorized 31,000,000 shares 210%
Additional Paid in Capital $8,437,322 USD 23%
Amortization of Intangible Assets $18,000 USD -39%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $43,146 USD -64%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%